Citation: S. Ramanathan-girish et M. Boroujerdi, Contradistinction between doxorubicin and epirubicin: in-vivo metabolism, pharmacokinetics and toxicodynamics after single- and multiple-dosing in rats, J PHARM PHA, 53(7), 2001, pp. 987-997
Citation: S. Ramanathan-girish et M. Boroujerdi, Contradistinction between doxorubicin and epirubicin: in-vitro interactionwith blood components, J PHARM PHA, 53(6), 2001, pp. 815-821
Authors:
Wallace, JD
Cuneo, RC
Bidlingmaier, M
Lundberg, PA
Carlsson, L
Boguszewski, CL
Hay, J
Boroujerdi, M
Cittadini, A
Dall, R
Rosen, T
Strasburger, CJ
Citation: Jd. Wallace et al., Changes in non-22-kilodalton (kDa) isoforms of growth hormone (GH) after administration of 22-kDa recombinant human GH in trained adult males, J CLIN END, 86(4), 2001, pp. 1731-1737
Citation: S. Vaidyanathan et M. Boroujerdi, Effect of tamoxifen pretreatment on the pharmacokinetics, metabolism and cardiotoxicity of doxorubicin in female rats, CANC CHEMOT, 46(3), 2000, pp. 185-192
Citation: S. Vaidyanathan et M. Boroujerdi, Interaction of dexrazoxane with red blood cells and hemoglobin alters pharmacokinetics of doxorubicin, CANC CHEMOT, 46(2), 2000, pp. 93-100
Citation: M. Boroujerdi, Secularization of Iran: A doomed failure? The new middle class and the making of modern Iran, MIDDLE E J, 54(1), 2000, pp. 126-127
Citation: K. Behnia et M. Boroujerdi, Inhibition of aldo-keto reductases by phenobarbital alters metabolism, pharmacokinetics and toxicity of doxorubicin in rats, J PHARM PHA, 51(11), 1999, pp. 1275-1282